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Coronary artery disease (CAD) and atherosclerosis are 
the leading causes of morbidity and mortality in the 
western as well as in developing countries of the world. 
Lowering cholesterol levels is known to be an effective 
preventive measure of atherosclerosis, reducing both 
coronary and all-cause mortality in patients with 
established coronary artery disease
1
. The effect of 
hypocholesterolemic therapy on primary prevention of 
atherosclerosis is still primary focus by researchers. So 
hypolipidemic drugs are still under research. Patient and 
doctor compliance of allopathic drugs is still major 
problem among various ethnic populations. Some 
cardiologists prefer allopathic hypolipidemic drugs and 
some are trying herbal hypolipidemic medications. 
Herbal medicines Garlic and Nigella sativa are getting 
popularity in western world as well as in east, due to 
their lesser adverse effects
2
. Garlic has been found to 
lower serum and liver cholesterol,  inhibit platelet 
growth and reduce oxidative stress. The cholesterol-
lowering effect of garlic is attributed to the 
bioavailability of allicin and its derivatives
3
. Garlic is 
one of the most popular herbal remedies and is steadily 
gaining interest in complementary and alternative 
medicine practice. There is a general belief that garlic is 
an effective and harmless mode of lowering cholesterol. 
This effect has not been linked to inhibition of HMG 
ABSTRACT 
Introduction: Hyperlipidemia, either primary or secondary causes atherogenetic abnormalities leading to coronary artery 
disease, cardiac arrest and arrhythmias. Herbal therapy for prevention or cure of Hyperlipidemia is replacing allopathic 
medicine due to their bioequivalence and good compliance features. This study was conducted to compare hypolipidemic 
effects of Garlic and Nigella sativa.  
Place of Study: Study was conducted at Jinnah Hospital Lahore from July 2013 to December 2013. Seventy five 
hyperlipidemic patients were enrolled after getting written consent which was approved by Ethics committee of the hospital.  
Grouping: They were divided in three equal groups comprising 25 patients in each group. Group-A was treated by Nigella 
Sativa, Group-B was advised to take Garlic 10 grams twice daily for two months. Group-C was on placebo.  
Results: After two months therapy it was observed by statistical analysis that Nigella sativa decreased total cholesterol 12.4 
mg/dl, triglycerides 16.7 mg/dl, and LDL cholesterol 27.3 mg/dl. HDL rise was 5.2 mg/dl. Garlic decreased total cholesterol 
17.9 mg/dl, triglycerides 19.9 mg/dl and LDL cholesterol 14.8 mg/dl. HDL cholesterol rise was 8.0 mg/dl.  
Conclusion: It was concluded from this study that there is little difference between hypolipidemic effects of two important and 
famous herbal medicines ie, Nigella sativa and Garlic. 
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CoA reductase and is presumably due to a different 
mechanism of action. Garlic has also been attributed 
with other protective cardiovascular effects like 
antihypertensive, anti-inflammatory, beneficial effects 
on blood rheology and coagulability, some of which may 
be independent of its cholesterol-lowering effect
4-7
. 
Nigella sativa is a pretty herb, seeds of which are 
commonly known as kalonji. Its chemical composition is 
moisture 7.43%, ash 4.14%, fixed oil 37%, volatile oil 
1.64%, albumin 8.2%, mucilage1.9%, organic acid 
precipitated by copper 0.38%, metarabin 1.36%, 
melanthin 1.4%, cellulose 8.32%, sugar 2.75%, arabic 
acid 3.41% and other substances dissolved by soda 
9.38%.
8 
Nigella sativa seeds used as a herbal medicine 
has many effects including cholerectic activity. Kalonji 
seeds also help in lowering blood cholesterol, blood 
pressure. It increases bile excretion which may play as 
hypolipidemic role in primary and secondary 
Hyperlipidemia
9
. Its different fractions (extracts) were 
used to observe its effects in whole blood clotting and 
plasma clot time. In vitro it significantly shortened both 
and bleeding time, partial thromboplastin time, 
prothrombin time and thrombin time in vivo it shortened 
bleeding time and partial thromboplastin time but 
prothrombin time and thrombin time remained 
unaffected.
10 
Seeds of Nigella sativa are given with 
butter and milk to cure obstinate hiccup. Seeds are 
employed as a purgative. They are also useful in 




PATIENTS & METHOD 
Research Design, duration, sample size and place of 
work: The research work was single blind placebo-
controlled, conducted at Jinnah Hospital, Lahore from 
July 2013 to December 2013. Seventy five 
hyperlipidemic patients were selected for research work. 
Written consent was taken from all patients. Specific 
Performa was designed for the research work.  
Selection of patients with Inclusion and Exclusion 
Criteria:  75 newly diagnosed primary hyperlipidemic 
patients were selected with age range from 18 to 70 
years. Exclusion criteria were hypothyroidism, diabetes 
mellitus, alcohol addictive patients, peptic ulcer, any 
gastrointestinal upset, renal impairment, and any hepatic 
or cardiac problem.  
Division/grouping of patients: All patients were 
divided in three groups (group-A, group-B, group-C), 25 
in each group. Their baseline experimental data was 
taken and filed in specifically designed Performa, at start 
of taking medicine, like lipid profile, blood pressure and 
pulse rate. Twenty five patients of group-A were advised 
to take one tea spoon of Nigella sativa (Kalonji), twice 
daily, i.e.; one tea spoon after breakfast and one tea 
spoon after dinner. Twenty five patients of group-B were 
advised to take Garlic 10 grams twice daily. Twenty five 
patients of group-C were provided placebo capsules, 
(containing grinded wheat), taking one capsule after 
breakfast and another before going to bed. All 
participants were advised to take these medicines for 
eight weeks. All participants were called every 2 weeks 
for follow up.  
Method for measurement of lipid profile: Serum lipid 
profile (total cholesterol, HDL-cholesterol, triglyceride) 
as well as other biochemical parameters were 
determined after a 12 hour overnight fast by standard 
methods. LDL-cholesterol level was calculated 
according to the Friedewald’s formula. Psychological 
status was determined at the first and last visit by the 
following self report questionnaires, all of which are 
considered sensitive and reliable.  
Biostatistical analysis: Data were expressed as the 
mean ± Standard Diviation and “t” test was applied to 
determine statistical significance as the difference. A 
probability value of <0.05 was considered as non-
significant and P<0.001 was considered as highly 
significant change in the results when pre and post-
treatment values were compared.  
RESULTS 
When results were compiled and statistically analyzed 
by using SPSS New Version 5, it was observed that 
Nigella sativa and Garlic decreased total-cholesterol, 
LDL-cholesterol, triglycerides significantly and 
increased HDL-cholesterol significantly as compared to 
placebo treatment. Pre and post-treatment values/results 
are shown in table 1, 2 and 3.   
 
Table 1:  Showing parameters values before & after treatment with their statistical significance in group A (Nigella Sativa) 
TC before treat: 269.13.72       After Treat: 256.77±2.41  Difference 12.4 % P-value= <0.001 
TG before treat: 208.68±2.81 After Treat: 191.94±2.90 16.7 % P-value= <0.001 
LDL-C before treat:177.64±2.76 After Treat: 150.32±1.46 27.3 % P-value= <0.001 
HDL-C before treat: 33.83±1.00 After Treat:   39.00±2.38 5.2 % P-value= <0.001 
 
Table 2:  Showing parameters values before and after treatment with their statistical significance in group B (Garlic) 
TC before treat: 287.33±1.30 After Treat:  269.44±2.70 Difference 17.9 % P-value= <0.001 
TG before treat: 221.65±2.06 After Treat: 201.72±1.47 19.9 % P-value= <0.001 
LDL-C before treat:203.17±2.01 After Treat: 188.42±1.00 14.8 % P-value= <0.001 
HDL-C before treat: 33.17±2.91 After Treat: 41.15±1.98 8.0 % P-value= <0.001 
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Table 3: Showing parameters values before and after treatment with their statistical significance in group C (Placebo) 
TC before treat: 254.61±1.02 After Treat:252.81±3.78 Difference 1.8 % P-value= >0.05 
TG before treat: 240.80±3.01 After Treat:241.70±2.44 0.9 % P-value= >0.05 
LDL-C before treat:170.55±2.65 After Treat:170.10±1.77 0.5 % P-value= >0.05 
HDL-C before treat: 34.43±2.87 After Treat:35.14±1.55 0.7 % P-value= >0.05 
KEY: P-value <0.01 stands for significant change, P-value >0.05 stands for non-significant change. All values are in mean and ± 
stands for standard error of mean. T-C= serum total cholesterol, TG= serum triglycerides, LDL-C= low density lipoprotein 
cholesterol, HDL-C= high density lipoprotein cholesterol. Treat: stands for treatment. All parameters pre and post-treatment are 
measured in mg/dl.  
 
DISCUSSION  
Among numerous genetic and lifestyle parameters, 
dyslipidemia is one of the most prominent risk factors for 
CAD. In the past decade, lowering LDL cholesterol 
(LDL-c), serum total cholesterol, serum triglycerides and 
increasing high density lipoprotein cholesterol (HDL-c)  
has been the major target in cardiovascular protection 
strategies. This approach has proven to be beneficial and 
effective in both primary and secondary prevention of 
cardiovascular disease (CVD). When analyzed 
biostatistically in this study the serum total cholesterol, 
triglycerides and serum low density lipoprotein 
cholesterol were decreased and  high density lipoprotein 
cholesterol was increased significantly when compared 
with placebo group. These results suggest that nigella 
sativa and Garlic  has a protective role in atherosclerosis 
and that is due to their hypolipidemic activity by different 
mechanisms. In our observations two months therapy by 
Nigella sativa decreased total cholesterol 12.4 %, 
triglycerides 16.7 %, LDL-cholesterol 27.3 % and 
increased HDL-cholesterol 5.2 % when pre and post 
treatment values were compared. All these changes are 
highly significant when analyzed statistically. These 
results match with results of study conducted by Cross 
DE et al.
12
  They observed 10.11 %, 15.00 %, 22.90 % 
decreased in total cholesterol, triglycerides and LDL-
cholesterol respectively. They proved 7.91 % increase in 
HDL-cholesterol. Their results support our results. 
Botsoglou NA et al
13
 described that herbal medications 
have more than one or two mechanism to balance plasma 
lipids in hyperlipidemic patients. LE PM et al
14
 have 
explained one important mechanism of action of Nigella 
sativa that oil of these seeds inhibits enterohepatic 
circulation causing biosynthesis of bile acids instead of 
cholesterol by hepatocytes. EI Dakhakhani M et al15 
observed that Nigella sativa reduces LDL-cholesterol 
lesser than HMG CoA-reductase inhibitors statins. They 
proved reduction in LDL-cholesterol only 10.75 % when 
one tea spoon of Nigella sativa oil was used in 16 
hyperlipidemic patients for four months. Their results are 
in contrast with our results. Reason for this mismatch in 
results may be less concentration of NS oil used in small 
number of patients, although they used it for four months. 
In our results Garlic reduced 17.9 %, 19.9 %, 14.8 % total 
cholesterol, Triglycerides and LDL-cholesterol 
respectively. HDL-cholesterol increased from  
33.17±2.91mg/dl to 41.15±1.98 mg/dl. In percentage it 
was 8.0 % increase. These results match with results of 
research work conducted by Raeesi M et al
16
 who proved 
almost same change in serum total cholesterol, 
triglycerides and HDL-cholesterol but in their results 
LDL-cholesterol reduction was much less than our results 
ie; only 7.3 %. They explained that LDL-cholesterol is 
important for consideration of development of 
atherosclerosis, CAD leading to cardiac arrhythmias and 
heart attack. Our results for reduction in LDL-cholesterol 
and boosting of HDL-cholesterol matches with results 
obtained by Islam MS and Choi H
17
 who proved 13.00 % 
reduction in LDL-cholesterol and 7.81 % increase in 
HDL-cholesterol by Garlic use for 3 months in 26 
hyperlipidemic patients.  Kim YJ et al
18
 proved no 
significant  change in HDL-cholesterol when 5 grams of 
Garlic  was used in 10 secondary hyperlipidemic patients 
for 10 days. So much change in results may be due to less 
amount of Garlic, lesser sample size and duration of 
intake of the selected herbal medication used in their 
research work.  
CONCLUSION AND RECOMMONDATION 
It was concluded from this research study that when 
hypolipidemic features of herbal medications are 
compared, their results are usually same. Patient 
compliance of herbal medications is good in our ethnic 
background. We recommend that research on 
hypolipidemic herbs/plants should be expanded and be 
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